Executive Producer
Dr. Al-Khatib is a tenured Professor of Medicine at Duke University Medical Center, a board-certified clinical electrophysiologist, and an experienced clinical researcher in cardiac arrhythmias. Her clinical expertise is in sudden cardiac death prevention, ventricular arrhythmias, implantable cardiac devices, and atrial fibrillation. Her research expertise lies in the design and conduct of clinical trials, outcomes research, cost-effectiveness analyses, electronic clinical decision support, and use of big data. She has more than 360 publications in peer-reviewed journals.

Dr. Al-Khatib has held numerous positions on Heart Rhythm Society committees and subcommittees and is a senior associate editor for Circulation. She chaired the 2017 American Heart Association/American College of Cardiology/Heart Rhythm Society on the Management of Ventricular Arrhythmias and the prevention of Sudden Cardiac Death. She was the Executive Producer for HRS’ HRX 2022 meeting and is the co-Executive Producer for HRS’ HRX 2023 meeting.

Executive Producer
Jag Singh is a Professor of Medicine at Harvard Medical School. He is the former Clinical Director of the Cardiology Division and the Roman W. DeSanctis Endowed Chair in Cardiology at Mass General Hospital. He is also the Founding Director of the Resynchronization and Advanced Cardiac Therapeutics Program, at the Massachusetts General Hospital Heart Center. Dr. Singh received his medical degree from Pune University, India and completed his internal medicine residency, cardiology and cardiac electrophysiology fellowships at Mass General Hospital. He also earned a doctorate from Oxford University, a Master of science in clinical investigation from MIT-Harvard and a research fellowship at the Framingham Heart Study.

Dr. Singh has over 400 peer reviewed publications and has given over 500 invited lectures at national and international conferences. He has served as an International Associate editor for the European Heart Journal, the former Deputy Editor of the Journal of American College of Cardiology: Clinical EP and Editor-in-chief of the Current Treatment Options in Cardiovascular Medicine. Dr. Singh’s is the national & global principal investigator on 6 ongoing multi-center clinical trials in device therapy and sensor strategies for heart failure and atrial fibrillation. Much of his current efforts are focused on healthcare redesign, digital health, and medical device innovations. 

Jag is a member of the Board of Trustees of the Heart Rhythm Society and the Co-Executive Producer of HRX 2023. He is the author of the forthcoming book, Future Care: Sensors, Artificial Intelligence, and the Reinvention of Medicine. 

Producer
Jennifer Silva is Director of Pediatric Electrophysiology and a Professor of Pediatrics and Biomedical Engineering at Washington University School of Medicine/St. Louis Children’s Hospital, and serves as the Faculty Fellow in Entrepreneurship for Washington University SOM. She serves on committees within the Heart Rhythm Society (Chair, Women in Electrophysiology; VChair, Growth and Leadership Opportunity for Women in Electrophysiology; Production Team, HRX; Member, Membership Committee) Pediatric and Congenital Electrophysiology Society (Vice President of Finance), American College of Cardiology (with leadership roles on the Innovation Council, Industry Advisory Forum, Applied Health and Innovation Council) and serves on the NIH-SBIR study section for Cardiovascular Innovation. She is a Senior Member of the National Academy of Inventors and serves on the Editorial Boards of numerous journals including Circulation: Arrhythmia and Electrophysiology, Heart Rhythm O2, and Cardiovascular Digital Health journals.

The scope of her research has been in innovation and emerging technologies with on developing and identifying clinical applications of new and emerging technologies within cardiac electrophysiology, particularly in the scope of wearable and advanced wearable technologies, including the extended realities.

Jennifer is the co-inventor and co-founder of SentiAR, Inc, a venture-backed software device spinout from Washington University which is developing the first mixed reality platform to display intraprocedural 3-dimensional holographic visualization of a patient’s cardiac anatomy with real time catheter locations with submission to the FDA in 2019.  In 2018, the company received a NIH-SBIR award for $2.2M, in 2021 closed a $5.1M Series A Round, and is currently closing a >$6M Series B. Most recently, she has co-founded a second company, Excera, Inc. which aims to improve outcomes for ultrasound-guided minimally invasive procedures. She has worked with several medical device companies including AliveCor, St Jude Medical/Abbott, Medtronic and Biosense Webster regarding development and implementation of novel technologies targeted to unmet clinical needs and development of regulatory pathways.